Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Assets (2019 - 2025)

Historic Assets for BioScience Health Innovations (BHIC) over the last 7 years, with Q3 2025 value amounting to $2.1 million.

  • BioScience Health Innovations' Assets rose 39710.22% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 million, marking a year-over-year increase of 39710.22%. This contributed to the annual value of $873788.0 for FY2024, which is 83565.34% up from last year.
  • BioScience Health Innovations' Assets amounted to $2.1 million in Q3 2025, which was up 39710.22% from $2.1 million recorded in Q2 2025.
  • BioScience Health Innovations' 5-year Assets high stood at $2.1 million for Q3 2025, and its period low was $374.0 during Q2 2021.
  • In the last 5 years, BioScience Health Innovations' Assets had a median value of $93388.0 in 2023 and averaged $405343.9.
  • As far as peak fluctuations go, BioScience Health Innovations' Assets crashed by 9836.5% in 2021, and later soared by 643903.74% in 2022.
  • BioScience Health Innovations' Assets (Quarter) stood at $96134.0 in 2021, then crashed by 70.52% to $28343.0 in 2022, then soared by 229.49% to $93388.0 in 2023, then skyrocketed by 835.65% to $873788.0 in 2024, then surged by 136.57% to $2.1 million in 2025.
  • Its Assets stands at $2.1 million for Q3 2025, versus $2.1 million for Q2 2025 and $1.4 million for Q1 2025.